Related Experiment Videos
Psychopharmacology in the aged. Research considerations in geriatric psychopharmacology
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
The Journal of clinical psychiatry·2001
Treatment of the agitation of late-life psychosis and Alzheimer's disease.
European psychiatry : the journal of the Association of European Psychiatrists·2001
SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.
Journal of sleep research·2001
Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program.
The Journal of clinical psychiatry·2001
Neuroleptic treatment of late-life schizophrenia.
Harvard review of psychiatry·2001
Treatment of affective illness in the elderly with drugs and electroconvulsive therapy.
Journal of geriatric psychiatry·1989
The epidemiology of depression in late life.
Journal of geriatric psychiatry·1989
Nonsuicidal mortality in late-life depression.
Journal of geriatric psychiatry·1989
I can't play ball anymore.
Journal of geriatric psychiatry·1989
Mood disorders following stroke: new findings and future directions.
Journal of geriatric psychiatry·1989
What DRGs mean to the patient and the provider.
Journal of geriatric psychiatry·1989
Comparative drug survival of biologic classes in psoriasis: a Japanese single-centre cohort study.
European journal of dermatology : EJD·2026
Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis.
European journal of dermatology : EJD·2026
Safety and Efficacy of Doravirine/Islatravir (100 mg/0.25 mg) Once Daily after Islatravir Dose Reduction from 0.75 mg: Week 96 Results from an Open-Label Phase 3 Study in Adults with HIV-1.
Journal of acquired immune deficiency syndromes (1999)·2026
Target engagement and efficacy in disease-modifying trials of synuclein-related disorders.
Brain : a journal of neurology·2026